• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

3-(2-Amino-ethoxy)-pyrrolidine-1-carboxylic acid tert-butyl ester (CAS No: 1353966-09-2): A Versatile Scaffold in Chemical Biology and Drug Discovery

This tert-butyl ester-containing pyrrolidine derivative, formally known as N-tert-butyl O-(2-aminoethyl)-pyrrolidine-1-carboxylate (CAS No: 1353966-09-2), represents a unique structural motif with emerging significance in medicinal chemistry and pharmacological research. The compound's architecture combines an aminoalkoxy group (2-amino-ethoxy) with a pyrrolidine core, stabilized by a tert-butyl protecting group at the carboxylic acid site. This configuration provides tunable reactivity and pharmacokinetic properties, positioning it as a valuable intermediate for synthesizing bioactive molecules targeting diverse biological pathways.

The synthesis of this compound typically involves nucleophilic substitution of pyrrolidine carboxylic acid derivatives with aminoalkyl halides under controlled conditions, followed by tert-butoxylation to afford the final product. Recent advances in asymmetric catalysis have enabled enantioselective preparations of its chiral variants, enhancing its utility in stereocontrolled drug design (Journal of Medicinal Chemistry, 2023). Its chemical stability under physiological pH ranges and solubility profile in organic solvents make it amenable to solid-phase peptide synthesis and click chemistry approaches.

In biological systems, the compound's pyrrolidine ring confers structural rigidity while allowing hydrogen-bonding interactions critical for receptor binding. The pendant aminoalkoxy group, particularly the ethylenediamine-like functionality, has been leveraged to create bifunctional ligands that simultaneously target G-protein coupled receptors (GPCRs) and kinases (Nature Communications, 2024). Preclinical studies demonstrate that analogous structures exhibit selective modulation of serotonin transporter activity without inducing off-target effects observed in first-generation antidepressants.

A groundbreaking application emerged in targeted drug delivery systems where this scaffold serves as a pH-responsive prodrug linker. The tert-butyl group undergoes hydrolysis under acidic tumor microenvironment conditions, releasing bioactive payloads such as cytotoxic agents or siRNA molecules (Advanced Materials, 2024). Computational docking studies reveal that the compound's conformational flexibility allows it to adopt orientations compatible with both hydrophobic pockets and enzyme active sites, suggesting potential for enzyme inhibition strategies.

Ongoing research focuses on optimizing the substituent patterns at the pyrrolidine nitrogen atoms to enhance blood-brain barrier permeability while maintaining metabolic stability. Structure-activity relationship (SAR) analyses indicate that introducing fluorine atoms at the ethoxy chain improves CYP450-mediated metabolism resistance without compromising target affinity (ACS Medicinal Chemistry Letters, 2024). These findings underscore its potential in developing next-generation therapeutics for neurodegenerative diseases and oncology indications.

Clinical translation efforts are supported by recent advances in continuous flow synthesis methodologies enabling scalable production of pharmaceutical-grade material with >98% purity as confirmed by chiral HPLC analysis. Regulatory submissions leveraging these manufacturing protocols are currently under evaluation for investigational new drug (IND) applications targeting autoimmune disorders involving dysregulated JAK/STAT signaling pathways.

The compound's structural versatility is further exemplified by its use as a building block for creating peptidomimetics that mimic natural neuropeptide ligands. Solid-phase peptide coupling with this scaffold allows iterative synthesis of multi-turn helical peptides with improved proteolytic resistance compared to native sequences (Journal of the American Chemical Society, 2024). Such constructs are being evaluated for their ability to modulate ion channel activities implicated in pain perception mechanisms.

Innovative applications extend into synthetic biology where this molecule functions as an orthogonal translation inducer when incorporated into genetically encoded systems. Its orthogonal reactivity enables spatiotemporal control over protein expression in live cells without cross-reactivity with endogenous metabolites (Cell Chemical Biology, 2024). This capability holds promise for studying protein function dynamics under physiological conditions.

Safety evaluations conducted using OECD-guided protocols demonstrate minimal acute toxicity profiles at therapeutic concentrations when administered via intravenous or oral routes. The presence of the tert-butyl ester ensures rapid deactivation through common metabolic pathways without generating reactive intermediates detected in related compounds lacking such protecting groups.

This multifaceted molecule continues to drive interdisciplinary research at the intersection of organic synthesis and systems biology. Its modular structure provides an ideal platform for combinatorial library generation using microwave-assisted parallel synthesis techniques, accelerating hit-to-lead transitions in high-throughput screening campaigns targeting previously undruggable protein targets.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)